Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas
about
Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomasDNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection.Silencing of RASSF3 by DNA hypermethylation is associated with tumorigenesis in somatotroph adenomas.Clinicopathological significance and potential drug target of T-cadherin in NSCLC.A pilot genome-scale profiling of DNA methylation in sporadic pituitary macroadenomas: association with tumor invasion and histopathological subtype.Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance.Aberrant methylation of CDH13 can be a diagnostic biomarker for lung adenocarcinomaThe significance of epigenetic alterations in lung carcinogenesis.Animal models of pituitary neoplasiaLoss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasisAltered gene expression and miRNA expression associated with cancerous IEC-6 cell transformed by MNNG.Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parametersChromosome 16q genes CDH1, CDH13 and ADAMTS18 are correlated and frequently methylated in human lymphoma.Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenomaPrognostic significance of CDH13 hypermethylation and mRNA in NSCLC.MicroRNAs in Human Pituitary Adenomas.Epigenetic regulation in gallbladder cancer: Promoter methylation profiling as emergent novel biomarkers.Cancer-Related Triplets of mRNA-lncRNA-miRNA Revealed by Integrative Network in Uterine Corpus Endometrial Carcinoma.Sera DNA Methylation of CDH1, DNMT3b and ESR1 Promoters as Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.Aberrant Methylation of T-cadherin Can Be a Diagnostic Biomarker for Colorectal Cancer.Expression and clinical significance of p120 catenin mRNA and protein in pancreatic carcinoma.Germline Mutations in CDH23, Encoding Cadherin-Related 23, Are Associated with Both Familial and Sporadic Pituitary Adenomas.Different levels of various glucocorticoid-regulated genes in corticotroph adenomas.Expression of E-cadherin, Slug and NCAM and its relationship to tumor invasiveness in patients with acromegaly.Differential DNA methylome profiling of nonfunctioning pituitary adenomas suggesting tumour invasion is correlated with cell adhesion.hTERT promoter methylation in pituitary adenomas.Promoter methylation of H-cadherin is a potential biomarker in patients with bladder transitional cell carcinoma.Reduced levels of E-cadherin correlate with progression of corticotroph pituitary tumoursNew directions in pharmacological treatment of acromegaly
P2860
Q28306491-E9375979-FAFB-4A40-A38A-62AB351B34AEQ33360111-4205D903-75E1-459B-BD3E-62213909E46FQ34650707-C053D5D1-2596-4AE7-9D0A-3480B8D20A2DQ34783319-08505CF2-11D7-447E-A810-DF13F8FE80C4Q35159730-AFB89475-41BC-4426-940E-4A1F16705F75Q35208036-20EC24EF-A365-4737-BA91-274D58A5E79AQ36229029-A6DC76C5-357E-4E74-803F-9EB7E430CB9BQ36457427-D1D7C265-7C9D-470D-9818-1F35E3351C06Q36486988-B2FFE508-6519-42AF-B327-9D6B3DA8218BQ36750694-948E09F4-2155-4CAC-9786-F92DAC1057F6Q37184148-8A09DAF9-2F0B-4F87-ADE4-0617C0B76D9AQ37284831-FD5BD5D9-B3CE-4ACD-B3F1-EB104428C038Q37407056-8D9FBF6B-9A72-407A-A43C-5CA6C945E96FQ37619445-F39C0F71-EE92-48E2-914E-DA120A3F729CQ38266450-22A12FA6-4D76-42D0-8D93-20B9D2006587Q38303604-D5F6C435-9B5E-4AD4-8BF3-016965BE362DQ38844664-E5C27F9A-329D-4AFD-B43A-553323831BC1Q38915810-75B82E2E-8EF3-4C70-A750-CFA4A04CF0EFQ41055982-25C2371D-EC97-4C94-974B-CBBC37FE3ED3Q41525873-C4FE722E-647A-439B-8FB5-3369070DECFBQ42270849-F58D77EE-81CB-4D65-A7E3-D5E4BEA8D86DQ43086692-BF381B48-3189-4EEA-916E-4757AAF21012Q44572315-9436F7C4-B48C-4639-8050-620AC3E6F82EQ47267466-A7652833-A2AB-47BD-AFA6-CE8986382E88Q50513833-991C92ED-329C-491C-9B9A-A1F81EC06E9FQ52149001-25C72972-37C2-447A-B512-415229195087Q54376271-B37A297A-A4B8-47F7-AB9E-82D579FE2C67Q58897880-C9BC4CFB-375E-48AA-BCDB-BEFF75D14159Q58897890-55D8A083-7F32-41D7-8EA5-AC1D1836C390
P2860
Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2007
@uk
name
Tumor-specific downregulation ...... ss of human pituitary adenomas
@en
Tumor-specific downregulation and methylation of the CDH13
@nl
type
label
Tumor-specific downregulation ...... ss of human pituitary adenomas
@en
Tumor-specific downregulation and methylation of the CDH13
@nl
prefLabel
Tumor-specific downregulation ...... ss of human pituitary adenomas
@en
Tumor-specific downregulation and methylation of the CDH13
@nl
P2093
P2860
P1433
P1476
Tumor-specific downregulation ...... ss of human pituitary adenomas
@en
P2093
Katsuhiko Yoshimoto
Noriko Mizusawa
Shozo Yamada
Toshiaki Sano
P2860
P2888
P304
P356
10.1038/MODPATHOL.3800965
P577
2007-09-14T00:00:00Z
P6179
1018055517